HIT Consultant October 22, 2024
Christopher Wooden, Senior Director, Business Marketing, IQVIA

A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). A brand can best meet its clinical and commercial objectives throughout its lifecycle by offering a well-orchestrated mix of information and resources in different digital and in-person formats that HCPs can easily access.

As with any multifaceted marketing and commercialization strategy, brand teams must identify and track the most relevant metrics to measure the impact of these programs. The main objective is to ensure all program elements are designed and delivered in a way that meets the specific needs and preferences of individual HCPs.

Results from a recent survey of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article